Qiagen Analyst Price Targets - Benzinga

Qiagen NV

QGENNYSE

Trade with Public

Trade with Public

$42.50

0.370.88%

At close: Sep 10, 5:00 PM EST

$42.44

0.310.74%

Pre-Market: 7:36 AM EST

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Dividends Compare Options Stock Report

Qiagen Analyst Price Targets

Wall Street analyst price targets and consensus rating for Qiagen (QGEN).

Price Target Range — 13 Quarters

Analyst Consensus — 14 Analysts

8Buy

6Hold

Consensus RatingNeutral# Analysts14Avg. Consensus PT$45Upside to Avg. PT+6.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 9, 2026	UBS	Dan Leonard	PT Cut	Neutral	$52→$47
Aug 10, 2026	Citigroup	Brendan Digan	PT Raise	Neutral	$38→$45
Aug 7, 2026	Barclays	Luke Sergott	PT Raise	Equal-Weight	$38→$40
Aug 7, 2026	JP Morgan	Casey Woodring	PT Raise	Overweight	$45→$50
Jun 23, 2026	Morgan Stanley	Steve Beuchaw	Upgrade	Equal-Weight→Overweight	$40→$42
May 18, 2026	Stifel	Daniel Arias	PT Cut	Hold	$50→$36
May 7, 2026	TD Cowen	Dan Brennan	PT Cut	Hold	$46→$40
Apr 29, 2026	JP Morgan	Casey Woodring	PT Cut	Overweight	$60→$45
Apr 29, 2026	Citigroup	Patrick Donnelly	PT Cut	Neutral	$55→$38
Apr 29, 2026	Barclays	Luke Sergott	PT Cut	Equal-Weight	$44→$38
Apr 29, 2026	Baird	Catherine Schulte	Upgrade	Neutral→Outperform	$53→$43
Apr 14, 2026	Barclays	Luke Sergott	Downgrade	Overweight→Equal-Weight	$44
Mar 13, 2026	Deutsche Bank	Jan Koch	Upgrade	Hold→Buy	$54
Feb 6, 2026	JP Morgan	Casey Woodring	PT Raise	Overweight	$55→$60
Feb 6, 2026	Citigroup	Patrick Donnelly	PT Cut	Neutral	$55→$55
Feb 6, 2026	Stifel	Daniel Arias	PT Raise	Hold	$45→$50
Jan 22, 2026	Deutsche Bank	Jan Koch	Downgrade	Buy→Hold	$52→$54
Dec 15, 2025	Barclays	Luke Sergott	PT Raise	Overweight	$53→$55
Dec 11, 2025	Citigroup	Patrick Donnelly	Downgrade	Buy→Neutral	$55→$50
Oct 2, 2025	Barclays	Luke Sergott	PT Cut	Overweight	$55→$53

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Maintains Neutral on Qiagen, Lowers Price Target to $47

UBS analyst Dan Leonard maintains Qiagen (NYSE:QGEN) with a Neutral and lowers the price target from $52 to $47.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Qiagen, Raises Price Target to $45

Citigroup analyst Brendan Digan maintains Qiagen (NYSE:QGEN) with a Neutral and raises the price target from $38 to $45.

Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Qiagen, Raises Price Target to $40

Barclays analyst Luke Sergott maintains Qiagen (NYSE:QGEN) with a Equal-Weight and raises the price target from $38 to $40.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Qiagen, Raises Price Target to $50

JP Morgan analyst Casey Woodring maintains Qiagen (NYSE:QGEN) with a Overweight and raises the price target from $45 to $50.

Benzinga Newsdesk

PRO
Morgan Stanley Upgrades Qiagen to Overweight, Raises Price Target to $42

Morgan Stanley analyst Steve Beuchaw upgrades Qiagen (NYSE:QGEN) from Equal-Weight to Overweight and raises the price target from $40 to $42.

Benzinga Newsdesk

PRO
Stifel Maintains Hold on Qiagen, Lowers Price Target to $36

Stifel analyst Daniel Arias maintains Qiagen (NYSE:QGEN) with a Hold and lowers the price target from $50 to $36.

Benzinga Newsdesk